4/A//SEC Filing
Berelowitz Michael 4/A
Accession 0001192482-21-000433
CIK 0001588972other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 4:07 PM ET
Size
5.4 KB
Accession
0001192482-21-000433
Insider Transaction Report
Form 4/AAmended
Berelowitz Michael
Director
Transactions
- Award
Stock Option (right to buy)
2021-04-20+38,012→ 38,012 totalExercise: $2.60Exp: 2031-04-20→ Common Stock (38,012 underlying)
Footnotes (2)
- [F1]This amended Form 4 is being filed to correct a typographical error in the exercise price of the stock options acquired on April 20, 2021 as reported on the Form 4 filed on April 22, 2021.
- [F2]The stock option will vest on April 20, 2022.
Documents
Issuer
Recro Pharma, Inc.
CIK 0001588972
Entity typeother
Related Parties
1- filerCIK 0001493383
Filing Metadata
- Form type
- 4/A
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 4:07 PM ET
- Size
- 5.4 KB